Month: August 2020

VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — FPX Nickel Corp. (FPX-TSX.V) (“FPX Nickel” or the “Company”) is pleased to announce the appointment of Stuart Harshaw, P. Eng., MBA, to the Board of Directors, effective immediately.  Mr. Harshaw is a leading figure in the global nickel market, with over 30 years’ experience in the production and marketing of nickel products worldwide, including in his roles as the Vice President of Marketing and Operations for Asia Pacific and Vice President, Ontario Operations for Vale S.A. (“Vale”) until 2017. “We are very happy to welcome Stuart to the FPX Nickel Board,” commented the Company’s Chairman, Peter Bradshaw.  “Stuart has deep operational experience in the development and management of major nickel operations in North America and Asia, and has an extensive background in...

TORONTO, Aug. 17, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) is pleased to report drill results from recent exploration drilling at the Valentine Gold Project, central Newfoundland (the “Project”). These latest results represent fire assay data from the latest nine drill holes completed in the new Berry Zone, located within the six-kilometre long Sprite Corridor. Highlights include:VL-20-835 intersected 2.96 g/t Au over 47 metres, including 7.55 g/t Au over 14 metres, and 32.25 g/t Au over 1 metre, and 27.00 g/t Au over 1 metre;VL-20-834 intersected 2.23 g/t Au over 30 metres, including 6.53 g/t Au over 8 metres;VL-20-829 intersected 2.12 g/t Au over 20 metres including 16.89 g/t Au over 1 metre, and 2.26 g/t Au over 10 metres, and 1.03 g/t Au over 17 metres, and 1.02 g/t Au over 11...

FORT WORTH, Texas, Aug. 17, 2020 (GLOBE NEWSWIRE) — Lilis Energy, Inc. (OTC Pink Marketplace: LLEXQ) (the “Company”), an exploration and production company operating in the Permian Basin of West Texas and Southeastern New Mexico, announced today that certain investment funds and entities affiliated with Värde Partners, Inc. (collectively, the “Värde Funds”) have declined to pursue a new money investment in the Company to sponsor a chapter 11 plan of reorganization.Therefore, in accordance with the terms of the Restructuring Support Agreement (the “RSA”) entered into among the Company and certain of its subsidiaries, all of the lenders under the Company’s existing RBL credit agreement, and the Värde Funds, as well as the Company’s debtor-in-possession financing facility, the Company will immediately begin pursuing a process to sell...

SHANGHAI and SAN FRANCISCO, Aug. 17, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced that F. Ty Edmondson has been named Chief Legal Officer. Mr. Edmondson will lead the global legal and compliance functions reporting to Dr. Samantha Du. Mr. Edmondson joins Zai Lab from Biogen Inc., a leading global biotech company, where he served as Senior Vice President, Chief Corporation Counsel and Assistant Secretary.“Ty brings decades of biopharmaceutical legal and compliance experience, having advised global companies, management teams and boards of directors in a diverse range of markets around the world,” said Dr. Samantha Du, Founder, Chairwoman and Chief Executive Officer of Zai Lab. “We are thrilled to have him as part of our experienced leadership team.”“I...

World’s First Fully Disposable Surgical Robot Achieved all Endpoints with No Intraoperative Adverse EventsRemotely Performed Procedures have the Potential to Reduce Radiation Exposure, Physical Strain and Cross Contamination to Both the Patients and the Surgical StaffHINGHAM, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), today announced the successful conclusion of its feasibility animal study using the Company’s LIBERTY™ Robotic System, the world’s first fully disposable surgical robotic system. The study met all of its end points with no intraoperative adverse events, which supports the Company’s objectives to allow physicians to conduct a catheter-based procedure from outside the catheterization laboratory (cath-lab), avoiding radiation exposure, physical strain and the risk of cross contamination. ...

 Achieves analytical performance for detecting active 3C-protease in a rapid visual format Initiates multicenter clinical trial at Assuta Ashdod Hospital and Tel Aviv University in Israel Technology opens potential for self-administered tests at home, school, work and airportsNEW YORK, NY REHOVOT, Israel, and SINGAPORE, Aug. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced positive proof-of-concept data for its proprietary 10-minute rapid point-of-care saliva-based test for detecting active SARS-CoV-2 infections. Based on these data, the Company has initiated a multicenter clinical...

BEIJING, Aug. 17, 2020 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618), China’s leading technology driven e-commerce company transforming to become the leading supply chain-based technology and service provider, today announced its unaudited financial results for the three months and six months ended June 30, 2020.Second Quarter 2020 HighlightsNet revenues for the second quarter of 2020 were RMB201.1 billion (US$1 28.5 billion), an increase of 33.8% from the second quarter of 2019. Net revenues from the sales of general merchandise products for the second quarter of 2020 were RMB64.0 billion (US$9.1 billion), an increase of 45.4% from the second quarter of 2019. Net service revenues for the second quarter of 2020 were RMB22.9 billion (US$3.2 billion), an increase of 36.4% from the second quarter of 2019.Income from operations...

All Clients Now Have Direct Access to Sandy Spring Bank’s People, Products and ServicesOLNEY, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (NASDAQ: SASR, “Sandy Spring”) announced today the full conversion of all Revere Bank systems and branding, completing the transition of Revere Bank into Sandy Spring Bank. Sandy Spring Bancorp, Inc. acquired Revere Bank effective April 1, 2020, and today is celebrated as “Client Day One” in recognition of providing all clients full access to Sandy Spring Bank’s people and comprehensive range of products and services.“We are thrilled to officially welcome all of our new clients. With the acquisition of Revere Bank now complete, we’ve deepened our presence in our core market, and our combined bank is poised for future growth,” said Daniel J. Schrider, President and CEO of Sandy...

NEW YORK and CLEVELAND and DALLAS, Aug. 17, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, and Taysha Gene Therapies, a patient-centric gene therapy company with a mission to eradicate monogenic CNS disease, today announced that they have entered into license and inventory purchase agreements for ABO-202, an adeno-associated virus (AAV) gene therapy for CLN1 disease (also known as infantile Batten disease). The agreements grant Taysha worldwide exclusive rights to intellectual property developed by scientists at the University of North Carolina at Chapel Hill (UNC) and Abeona, and Abeona know-how relating to the research, development, and manufacture of ABO-202. The therapy was originally developed in the lab of Steven Gray, Ph.D., Associate Professor at UT Southwestern...

RNSHorizon Discovery Group plcResults for the Six Months Ended 30 June 2020Cambridge, UK, 17 August 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Group” or “the Company”), a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development, today announces its unaudited results for the six months ended 30 June 2020.Group Financial HighlightsReported revenue of £22.4m (HY19: £26.1m)1 down 13.9% (15.5% on a constant currency basis) largely due to impact of COVID-19 pandemic and a rapid reduction of academic research work in Q2 2020Revenue decline largely due to rapid reduction of academic research work caused by COVID-19 pandemic in Q2 2020 and was broadly within the range of our expectationsOrder...